Rolf Apweiler

Rolf Apweiler serves as Director of the European Bioinformatics Institute (EMBL-EBI), part of the European Molecular Biology Laboratory, a position he has held since 2015. Previously, he was Associate Director (2012-2015) and led multiple critical protein resources including UniProt and InterPro. His leadership extends to directing Open Targets since 2018 and spearheading EMBL-EBI's contribution to the European COVID-19 Data Platform.

Apweiler's research spans Bioinformatics, Proteomics, and Genomics, with significant contributions to protein annotation methods, proteomics data standards, and major biological databases. His work enables comprehensive analysis of proteome sets across entire organisms and has established foundational resources for the global scientific community.

His publication portfolio demonstrates consistent leadership in developing critical bioinformatics infrastructure, with major contributions including UniProt, PRIDE, IntAct, and InterPro. These resources form the backbone of modern proteomics research and have been widely adopted across the life sciences.

• HUPO Distinguished Achievement Award in Proteomics (2004)
• EMBO Member (2011)
• ISCB Fellow (2015)
• President of Human Proteomics Organisation (2007-2008)

As Director of EMBL-EBI, Apweiler oversees one of the world's leading bioinformatics institutions, managing extensive research programs, international collaborations, and major data infrastructure projects. His leadership in Open Targets demonstrates significant engagement with translational research connecting basic science to drug discovery.

Apweiler's teams maintain several critical global resources including PRIDE (proteomics identifications), IntAct (molecular interactions), and UniProt (protein knowledgebase), forming an integrated ecosystem for biological data analysis.